Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders.Journal of Ocular Pharmacology and Therapeutics coverage includes:GlaucomaCataractsRetinal degenerationOcular infection, trauma, and toxicologyOcular drug delivery and biotransformationOcular pharmacotherapy/clinical trialsOcular inflammatory and immune disordersGene and cell-based therapiesOcular metabolic disordersOcular ischemia and blood flowProliferative disorders of the eyeEyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.